China CNC Daily Insight · Issue #15

China's CNC Brain — GSK (广州数控), the Domestic Controller Champion

A daily brief on China's CNC industry · Figures as of August 2026 · Prepared for buyers, investors and overseas partners. ← All insights · ← GREE CNC
Contents

Every machine tool has a brain — the CNC system — and in China that brain is increasingly domestic. GSK (广州数控 / Guangzhou Numerical Control) is the volume champion of that domestic brain, with a company-stated ~50% share of China's CNC-system market for over two decades. For an overseas buyer, GSK is the lens that makes "Chinese controller" concrete: mature at economy and mid-tier, climbing into five-axis, and a direct reference point for Gree's own GNC controller.

1991
Founded, Guangzhou (Huangpu)
~50%
Domestic CNC-system share (company-stated, 25+ yrs)
1.5M+
Cumulative CNC systems shipped (company-stated)
Private
No audited consolidated financials
980 / 25i
Economy series / high-end five-axis (RTCP)
CNC control cabinet and operator console inside a Chinese factory
Fig 1 · A CNC control system console — the "brain" of a machine tool. GSK is China's volume champion at making this brain domestically. Photorealistic render, not a specific vendor's facility.

1 · Why the Controller Is the Real "Brain"

Two machines can look identical on the floor and behave completely differently because of what sits inside the cabinet. The CNC system decides interpolation accuracy, look-ahead, thermal/compensation behavior, five-axis RTCP math, and how the servo axes respond. It is the single component that most defines a machine's character and price.

For China's machine-tool rise, the controller was the last big dependency after the castings, ballscrews and spindles were largely localized. GSK is the company that closed that gap at volume: an economy GSK 980 made Chinese lathes affordable and serviceable nationwide, and the 25i/27i family pushed the same brand into five-axis territory. That is why GSK is the right anchor for a "domestic controller" brief — it spans the whole range.

This issue pairs naturally with our earlier Huazhong CNC brief (the technology-led listed player) and the import-substitution piece. GSK is the scale counterpart to Huazhong's tech.

2 · GSK Profile

AttributeDetail
Full name广州数控设备有限公司 (Guangzhou Numerical Control Equipment Co., Ltd.)
Founded / HQ1991 · Guangzhou, Huangpu District, Guangdong
OwnershipPrivate (not listed) — no audited consolidated financials
Core businessCNC systems, servo drives & servo motors, industrial-robot controllers & robots
Scale claimsCumulative CNC systems >1.5M sets; ~100k systems produced & sold per year (company-stated)
Industry roleDescribed in official media as a "dual chain-leader" (双链主) for China's machine-tool and industrial-robot industry chains
Substitute record25i / 27i high-end systems reported to have replaced imports in NEV and rail-transit applications

Source: official-media coverage (Workers' Daily / 中工网, 2025-06), vendor/product descriptions aggregated from multiple secondary sources. Revenue figures are deliberately omitted — see credibility note.

Close-up of a CNC control panel showing a machining program Six-axis industrial robotic arm in a manufacturing cell
Fig 2 · Left: a CNC control panel running a machining program — the operator-facing half of the "brain". Right: an industrial robot, the other half of GSK's business (RB-series robot controllers). Photorealistic renders.

3 · Product Lines: 980 / 25i–27i / RB Robots

LinePositioningNotes
GSK 980 seriesEconomy lathe / mill systemsThe high-volume workhorse; ISO G-code compatible, friendly UI, huge service network. The default brain of countless Chinese economy machines.
GSK 25i / 27i / 218High-end, five-axis capableRTCP (rotary tool-center-point compensation), reportedly ±0.005 mm class positioning; 32-bit multi-core, ~0.5 ms interpolation. Used where import substitution matters (NEV, rail).
RB-series robotsIndustrial robots + controllersRepeatability ≤0.02 mm class, 3–50 kg payloads; GSK is both a robot maker and a robot-controller supplier to others.
Servo & motorsIn-house motion layerSelf-made servo drives and servo motors — the same vertical-integration logic Gree applies to its spindle and linear motor.

Why the line-up matters

GSK is unusual in covering the full stack — controller, servo, motor, robot — under one brand. That vertical breadth is what lets a Chinese machine builder source a coherent motion package domestically. For an overseas buyer it means a Chinese machine's "domestic controller" is rarely a single lonely box; it is usually a matched controller+servo ecosystem, which is part of why Chinese machines are both cheap and fast to support.

4 · Market Position & the ~50% Question

GSK is widely described — including in official state-media reporting — as holding about half of China's domestic CNC-system market for over 25 consecutive years, and as having shipped more than 1.5 million CNC systems cumulatively. That is a genuinely dominant position in the economy and mid tiers.

Honesty flag on the ~50% figure: This number is company-stated and repeated in official media, not independently audited by a third party we can cite. We rate it Medium confidence: directionally it is clearly "the largest domestic player by a wide margin," but the precise percentage should be treated as a claim, not a verified statistic. We apply the same caution to cumulative-shipment counts.

The flip side is financial transparency. Because GSK is private, there is no audited consolidated revenue or profit to verify. Third-party research reports we reviewed gave wildly different 2024 revenue figures — roughly RMB 1.5B (woodworking segment), RMB 2.2B (injection-robot segment), RMB 2.87B (CNC lathe segment), RMB 4.27B (CNC-device segment), and RMB 9.6B (robot-equipment segment). Those numbers measure different slices, and none is authoritative. We therefore quote no single revenue and rate any GSK financial figure Low confidence.

5 · This Week's Gree CNC Angle

GSK and Gree's GNC sit in the same "domestic brain" category — but Gree plays a different game

Gree's machines run its own proprietary controller, branded GNC. GSK, Huazhong and KEDE are the other domestic controllers. So when an overseas buyer asks "is the controller Chinese?", the honest answer for many Chinese machines is "yes — often a GSK 980, a GSK 25i, or a Gree GNC." Three readings:

  • GSK is proof, not a rival, for the ecosystem thesis. Its scale shows Chinese controllers are mature and cheap at volume. That lowers the risk premium a buyer attaches to "domestic brain" machines generally — including Gree's.
  • Gree's differentiator is the package, not just the chip. Gree pairs GNC with an in-house spindle and linear motor, plus a machine + robot + thermal + process bundle for production-scale buyers. GSK sells the brain (and robots); Gree sells the whole production cell around its own brain.
  • The buyer's real question is the tier. Economy GSK 980, high-end GSK 25i (five-axis RTCP), Gree GNC, or FANUC/Siemens — each implies a different capability and price class. Name the controller tier, and you name half the machine's character. We always recommend asking.

6 · Objective Limits & Risks

Transparency gap (private company)

No audited financials means less ability to verify durability, R&D intensity or service-network health from public data. For a buyer, that argues for direct factory audit and reference-site checks rather than relying on published scale claims.

Economy-tier perception

GSK's volume base is the 980 economy series. A machine "with a domestic controller" may mean a 980-class brain — perfectly fine for general work, but not the same as a 25i five-axis RTCP or a FANUC 31i. Verify the exact model, not just the brand.

High-end still catching up

The 25i/27i family is real and used in substitution cases, but at the very top — sustained ultra-precision, deep five-axis process know-how, global service — FANUC/Siemens/Siemens still set the benchmark. GSK is climbing, not yet level.

7 · Data Credibility Rating

ClaimSourceConfidence
Founded 1991, Guangzhou; private; controller+servo+robot scopeConsistent across official-media & vendor descriptionsHigh
Product lines 980 / 25i–27i (RTCP) / RB robotsMultiple secondary & vendor sources agreeHigh
~50% domestic CNC share / 1.5M+ cumulative systemsCompany-stated, repeated in official mediaMedium
25i ±0.005mm, 0.5ms interpolation, 32-bit multi-coreSecondary technical specs (not vendor datasheet verified by us)Medium
Revenue / profit (any single figure)Private company; third-party estimates conflict (RMB 1.5B–9.6B by slice)Low
"Dual chain-leader" industry roleOfficial-media descriptionMedium

8 · Guidance by Use Case

Overseas buyer / distributor

Treat GSK as the reference for "what a domestic Chinese controller is." If a machine you are quoted uses a GSK 980, you are in economy/mid territory — great value, verify the job fits. If it uses a GSK 25i/27i or a Gree GNC, you are in five-axis-capable territory — verify RTCP, accuracy class and a local reference site. Always name the exact controller model in the spec sheet; "domestic controller" is not a specification.

Investor

GSK itself is not investable (private). The investable read is the trend: domestic controllers are taking share from imports at volume, which lifts the whole Chinese machine-tool stack (Gree, Topstar, KEDE, Haitian) and the component layer beneath it. Watch listed proxies — Huazhong (300161), Topstar (300607), Yiheda (301029) — as the verifiable way to track the same thesis.

Technology / supply-chain partner

GSK is a concrete procurement and benchmarking contact for controller+servo+robot packages sourced in China. For Gree's own supplier mapping, GSK shows how far vertical integration of the motion layer has already gone domestically — useful when weighing make-vs-buy on spindle, servo and controller internals.

Frequently Asked Questions

Is GSK the same as Gree's controller?

No. GSK (广州数控) is an independent CNC-system and robot supplier. Gree uses its own proprietary controller, branded GNC. Both sit in the 'domestic controller' category alongside Huazhong CNC and KEDE, but they are separate companies. GSK sells controllers and robots to many Chinese machine-tool builders; Gree builds complete machines around its own GNC plus in-house spindle and linear motor.

Is GSK a publicly listed company?

No. GSK is a private Chinese enterprise (founded 1991, Guangzhou). That matters for this series: unlike Topstar (300607) or Yiheda (301029), GSK publishes no audited consolidated financials. Third-party estimates of its revenue vary wildly (from ~RMB 1.5B to ~RMB 9.6B depending on which segment is measured), so we do not quote a single revenue figure and rate any financial claim Low confidence.

What does GSK actually make?

Primarily CNC systems (GSK 980 economy series, GSK 25i/27i/218 high-end five-axis with RTCP), servo drives and servo motors, plus RB-series industrial-robot controllers and robots. It is a controller-and-component champion, not primarily a machine-tool OEM — though it also builds some complete machines. GSK is described in official media as a 'dual chain-leader' for both China's machine-tool and industrial-robot industry chains.

Why should an overseas buyer care about a domestic controller brand?

Because the controller tier inside a Chinese machine decides a lot of its behavior and price. A machine may ship with an economy GSK 980, a high-end GSK 25i/27i (five-axis, RTCP), Gree's GNC, or a FANUC/Siemens. GSK's scale proves Chinese controllers are mature at volume and low cost — useful context when you evaluate any Chinese machine. The buyer's job is to ask which controller tier is inside, and at what capability class.

← Back to all China CNC Daily Insights